Diabetic cardiomyopathy and its prevention by metallothionein: experimental evidence, possible mechanisms and

Lu Cai1

  • 1Department of Medicine, the University of Louisville, Louisville, KY 40202, USA. L0cai001@louisville.edu

Insights

Metallothioneins (MTs) protect the heart from diabetic cardiomyopathy by acting as antioxidants and regulating zinc. Zinc supplementation may offer a clinical strategy to prevent diabetic heart complications.

Area of Science:

  • Cardiology
  • Biochemistry
  • Endocrinology

Background:

  • Diabetic cardiomyopathy is a major cause of mortality in diabetic patients, with oxidative stress being a primary driver.
  • Metallothioneins (MTs) are antioxidant proteins with known protective roles in the heart.
  • Understanding MT's mechanisms in diabetic hearts is crucial for developing preventative strategies.

Purpose of the Study:

  • To review the role of Metallothioneins (MTs) in preventing diabetic cardiomyopathy.
  • To highlight MT's antioxidant functions and mechanisms in the diabetic heart.
  • To discuss the clinical implications of MT induction, particularly via zinc supplementation.

Main Methods:

  • Review of existing research on MTs in diabetic cardiomyopathy.
  • Analysis of experimental evidence from transgenic mice models (cardiac-specific MT-overexpressing and OVE26MT mice).
  • Examination of MT's roles in calcium regulation, zinc homeostasis, insulin sensitization, and antioxidant action.

Main Results:

  • MTs demonstrate significant cardiac protection against diabetes through antioxidant and other mechanisms.
  • MTs play critical roles in maintaining redox homeostasis and zinc balance in the heart.
  • MTs are inducible by agents like zinc, suggesting therapeutic potential.

Conclusions:

  • MTs are key players in protecting the heart from diabetic damage.
  • Zinc supplementation is a promising clinical approach to induce cardiac MT and prevent diabetic cardiomyopathy.
  • Further research into MT's mechanisms and clinical application is warranted.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...